Nara Organics Issues Nationwide Recall of All Infant Formula Over Botulism Risk

Jun 15, 2026

Nara Organics has issued a nationwide recall of all its infant formula after the FDA and CDC linked it to three cases of infant botulism. The affected infants are hospitalized in California, Washington, and Pennsylvania, with no reported fatalities. While no formula has tested positive for C. botulinum, Nara initiated the recall "in an abundance of caution." The product was sold at Target and online from July 2025 to June 2026.

Nara Organics formula recall

▪Nara Organics is voluntarily recalling all of its infant formula sold in the United States due to a potential risk of bacterial contamination.
▪Nara Organics stated that none of its formula has tested positive for C. botulinum and the recall is being issued "in an abundance of caution."

Infant botulism cases

▪Symptoms of infant botulism can include constipation, poor feeding, drooping eyelids, breathing difficulties, and potentially respiratory arrest.
▪The FDA and CDC informed Nara Organics about three cases of infant botulism in babies who had consumed the company's formula.
▪The three infants with botulism were hospitalized for treatment in California, Washington, and Pennsylvania.
▪Infant botulism is caused by ingesting Clostridium botulinum spores, which produce toxins in a baby's immature digestive system.

FDA investigation findings

▪The FDA reported on June 13, 2026, that there have been no fatalities associated with the three infant botulism cases.
▪In April 2026, the FDA stated that tests confirmed the nation's infant formula supply was safe for consumption, containing only very low levels of contaminants.

Product distribution details

▪The recalled Nara Organics powdered infant formula was sold at Target stores, Target.com, and Nara.com between July 2025 and June 2026.
▪The recalled Nara Organics formula was not sold outside of the United States.

Recent formula safety incidents

▪Earlier in 2026, a multi-state infant botulism outbreak was linked to ByHeart's powdered formula.
▪In May 2026, a2 Milk recalled three batches of its a2 Platinum formula in the U.S. after detecting the toxin cereulide.